Veru to present at the jefferies healthcare conference

Miami, fl, may 24, 2023 (globe newswire) -- veru inc. (nasdaq: veru), a late clinical stage biopharmaceutical company focused on developing novel medicines for the treatment of breast cancer and for sars-cov-2 and other viral ards-related diseases, today announced that mitchell steiner, m.d., chairman, president and chief executive officer of veru, will present at the upcoming jefferies healthcare conference on wednesday, june 7, 2023 at 11 a.m. et.
VERU Ratings Summary
VERU Quant Ranking